Quantcast

Latest MicroBiome Therapeutics LLC Stories

2014-06-23 16:24:44

--Microbiome Modulator NM504 Significantly Improved Blood Glucose Control and Other Metabolic Parameters in Patients with Prediabetes and Type 2 Diabetes-- CHICAGO and BROOMFIELD, Colo., June 23, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM) LLC, (MBT) today presented positive results from a clinical trial of microbiome modulator NM504 in prediabetes and type 2 diabetes at ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society....

2014-06-17 08:28:54

- Recent Publication Shows Metformin Improves Glycemic Control by Modulating the Gut Microbiome and Triggering Specific Cellular and Immune Mechanisms - BROOMFIELD, Colo., June 17, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM) LLC, (MBT) today reported that a recently published scientific study shows that the diabetes drug, metformin, alters the bacterial populations in the gut in favor of a bacterial species that exerts specific cellular and immunological effects, resulting...

2014-04-08 08:30:26

--MBT Previously Reported Statistically Significant Positive Topline Results from this First Double-Blind, Randomized Clinical Trial of a Microbiome Modulator for Diabetes-- BROOMFIELD, Colo., April 8, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM) LLC, (MBT) today announced that data from the company's clinical trial of microbiome modulator NM504 in development for type 2 diabetes and prediabetes has been accepted for a Poster Preview Presentation at ICE/ENDO 2014, the joint...

2014-02-18 08:30:35

--Statistically Significant Positive Results from First Double-Blind, Randomized Clinical Trial of a Microbiome Modulator for Diabetes-- BROOMFIELD, Colo., Feb. 18, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM)( )LLC, (MBT) today announced positive top-line results from the company's clinical trial of lead microbiome modulator NM504 in development for type 2 diabetes and prediabetes. NM504 is designed to improve glucose tolerance and other metabolic parameters in patients with...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.